BackgroundCheck.run
Search For

Jenny P Wai, 663867 Kent Way, South San Francisco, CA 94080

Jenny Wai Phones & Addresses

3867 Kent Way, S San Fran, CA 94080    415-8191219   

South San Francisco, CA   

San Francisco, CA   

Seattle, WA   

Work

Company: Housewife

Education

School / High School: Universiti Kebangsaan Malaysia 1993 Specialities: Bachelor of Economics in Industrial Economics

Skills

Typing
loan documentation

Mentions for Jenny P Wai

Jenny Wai resumes & CV records

Resumes

Jenny Wai Photo 33

Jenny Wai

Location:
San Francisco Bay Area
Industry:
Information Technology and Services
Jenny Wai Photo 34

Sales And Marketing Associate

Location:
San Francisco, CA
Industry:
Internet
Work:
Cyber Lmj Feb 2011 - Feb 2012
Business Development Executive
Elephanti Feb 2011 - Feb 2012
Sales and Marketing Associate
Education:
Monash University 2009 - 2011
Bachelor of Commerce, Bachelors
Temasek Polytechnic 2006 - 2008
Skills:
Business Development, Lead Generation, Online Marketing, Sales Management, Digital Marketing, Online Lead Generation, Internet Services, Mobile Applications, Key Account Management
Jenny Wai Photo 35

Jenny Wai

Jenny Wai Photo 36

Jenny Fook Wai Cheng - US

Work:
Housewife Apr 2005 to 2000 Public Bank Berhad Mar 1997 to Apr 2005
Senior Operations Officer (Loans Department)
Education:
Universiti Kebangsaan Malaysia 1993 to 1996
Bachelor of Economics in Industrial Economics
Pre-University 1991 to 1992
Skills:
Typing<br/>loan documentation

Publications & IP owners

Wikipedia

Jenny Wai Photo 37

Jenny Kwan

Jenny Wai Ching Kwan is a Hong Kong-born Canadian politician. She is currently a Member of the Legislative Assembly (MLA) of British Columbia, and a senior

Us Patents

3-(1H-Pyrazol-4-Yl)Pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor

US Patent:
2020006, Mar 5, 2020
Filed:
Nov 5, 2019
Appl. No.:
16/674546
Inventors:
- Rahway NJ, US
Jianming Bao - South San Francisco CA, US
Melissa Egbertson - Ambler PA, US
Xiaolei Gao - Bridgewater NJ, US
Scott T. Harrison - Elkins Park PA, US
Sandra L. Knowles - Princeton NJ, US
Chunsing Li - Shanghai, CN
Michael Man-Chu Lo - Bedminster NJ, US
Zhaoyang Meng - Ambler PA, US
Michael T. Rudd - Collegeville PA, US
Oleg B. Selyutin - West Windsor NJ, US
David M. Tellers - Lansdale PA, US
Ling Tong - Warren NJ, US
Jenny Miu-Chun Wai - Harleysville PA, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
MSD R & D (China) Co., Ltd. - Shanghai
International Classification:
A61K 31/4439
A61P 25/28
A61P 25/18
A61P 25/16
A61K 31/437
C07D 401/14
C07D 405/14
C07D 471/04
Abstract:
The present invention is directed to pyrazol-4-yl-pyridine compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which M4 muscarinic acetylcholine receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which M4 muscarinic acetylcholine receptors are involved.

3-(1H-Pyrazol-4-Yl)Pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor

US Patent:
2019000, Jan 3, 2019
Filed:
Dec 19, 2016
Appl. No.:
16/062500
Inventors:
- Rahway NJ, US
Jianming Bao - South San Francisco CA, US
Melissa Egbertson - Ambler PA, US
Xiaolei Gao - Bridgewater NJ, US
Scott T. Harrison - Elkins Park PA, US
Sandra L. Knowles - Princeton NJ, US
Chunsing Li - Shanghai, CN
Michael Man-Chu Lo - Bedminster NJ, US
Zhaoyang Meng - Ambler PA, US
Michael T. Rudd - Collegeville PA, US
Oleg B. Selyutin - West Windsor NJ, US
David M. Tellers - Lansdale PA, US
Ling Tong - Warren NJ, US
Jenny Miu-Chun Wai - Harleysville PA, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/4439
A61K 31/437
A61P 25/16
A61P 25/18
A61P 25/28
Abstract:
The present invention is directed to pyrazol-4-yl-pyridine compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which M4 muscarinic acetylcholine 5 receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which M4 muscarinic acetylcholine receptors are involved.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.